Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 368 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Hägg S, Jönsson AK, Ahlner J. Current evidence on abuse and misuse of gabapentinoids. Drug Saf 2020;43:1235-54. [Ref.ID 103789]
2.Enlace a cita original Cita con resumen
Patorno E, Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Bateman BT. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLOS Medicine 2020;17:1 de septiembre. [Ref.ID 103726]
3. Cita con resumen
Blotière P-O, Miranda S, Weill A, Mikaeloff Y, Peyre H, Ramus F, Zureik M, Coste J, Dray-Spira R. Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study. BMJ Open 2020;10:e034829. [Ref.ID 103654]
4. Cita con resumen
Mathieson S, Lin C-WC, Underwood M, Eldabe S. Pregabalin and gabapentin for pain. BMJ 2020;369:28 de abril. [Ref.ID 103627]
5.Enlace a cita original Cita con resumen
Alsfouk BAA, Brodie MJ, Walters M, Kwan P, Chen Z. Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy. JAMA Neurology 2020;77:574-81. [Ref.ID 103540]
6. Cita con resumen
Mahase E. Gabapentinoids: has reclassification really solved the problem?. BMJ 2020;368:13 de enero. [Ref.ID 103509]
7. Cita con resumen
Blotière P-O, Raguideau F, Weill A, Elefant E, Perthus I, Goulet V, Rouget F, Zureik M, Coste J, Dray-Spira R. Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology 2019;93:. [Ref.ID 103248]
8. Cita con resumen
9. Cita con resumen
Kranzler HR, Feinn R, Morris P, Hartwell EE. A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder. Addiction 2019;114:septiembre. [Ref.ID 103238]
11. Cita con resumen
Smith BH, Fletcher EH, Calvin LA. Opioid prescribing is rising in many countries. BMJ 2019;367:17 de octubre. [Ref.ID 103203]
12. Cita con resumen
13. Cita con resumen
Tracy DK. Gabapentinoids linked to new risks, including suicidal behaviour. BMJ 2019;365:12 de junio. [Ref.ID 103153]
15. Cita con resumen
Randolph AC, Lin Y-L, Volpi E, Kuo Y-F. Tricyclic antidepressant and/or ?-aminobutyric acid–analog use is associated with fall risk in diabetic peripheral neuropathy. J Am Geriatr Soc 2019;67:junio. [Ref.ID 103149]
16.Enlace a cita original Cita con resumen
Finnerub NB. Nonnarcotic methods of pain management. N Engl J Med 2019;380:20 de junio. [Ref.ID 103139]
17.Enlace a cita original Cita con resumen
Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]
18.Enlace a cita original Cita con resumen
19.Enlace a cita original Cita con resumen
Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med 2019;179:mayo. [Ref.ID 103073]
20.Enlace a cita original Cita con resumen
Brutcher RE, Kurihara C, Bicket MC, Moussavian-Yousef P, Reece DE, Solomon LM, Griffith SR, Jamison DE, Cohen SP. Compounded topical pain creams to treat localized chronic pain: a randomized controlled trial. Ann Intern Med 2019;170:mayo. [Ref.ID 103014]
Seleccionar todas
 
 1 a 20 de 368 siguiente >>